Budapest, Hungary

Lászó Orfi

This inventor holds 1 USPTO granted patent. Top assignee: Vichem Chemie Kutató Kft.. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lászó Orfi: Innovator in Pharmaceutical Chemistry

Introduction

Lászó Orfi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of new drug candidates.

Latest Patents

Lászó Orfi holds a patent for "Styryl quinazoline derivatives as pharmaceutically active agents." This invention relates to styryl quinazoline derivatives of the general formula (I) and includes pharmaceutically acceptable solvates, hydrates, salts, regioisomeric, and polymorphic forms. The compounds have been identified as new drug candidates for the prevention and treatment of diseases related to dysfunctions of hematopoiesis and cancer, particularly myeloid leukemia. Additionally, these compounds have antibacterial properties, making them potential agents for treating bacterial infectious diseases. He has 1 patent to his name.

Career Highlights

Lászó Orfi is associated with Vichem Chemie Kutató Kft., where he continues to advance his research in pharmaceutical applications. His work has positioned him as a key figure in the development of innovative therapeutic agents.

Collaborations

He collaborates with esteemed colleagues such as Ferenc Baska and György Kéri, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Lászó Orfi's contributions to pharmaceutical chemistry highlight his role as an inventor dedicated to improving healthcare through innovative drug development. His work continues to pave the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…